We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

148 hedge funds and large institutions have $839M invested in Cardiovascular Systems, Inc. in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 49 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 49

3% more call options, than puts

Call options by funds: $486K | Put options by funds: $473K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

7% less funds holding

Funds holding: 159148 (-11)

26% less capital invested

Capital invested by funds: $1.13B → $839M (-$288M)

36% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 28

Holders
148
Holders Change
-11
Holders Change %
-6.92%
% of All Funds
3.3%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
59
Reduced
49
Closed
28
Calls
$486K
Puts
$473K
Net Calls
+$13K
Net Calls Change
+$1.15M
Name Holding Trade Value Shares
Change
Change in
Stake
Legal & General Group
126
Legal & General Group
United Kingdom
$173K +$34.4K +1,082 +22%
Canada Life
127
Canada Life
Manitoba, Canada
$88K
WEC
128
Winslow Evans & Crocker
Massachusetts
$86K
Zurich Cantonal Bank
129
Zurich Cantonal Bank
Switzerland
$82K
PCM
130
Prelude Capital Management
New York
$81K +$56.1K +1,766 +162%
AIP
131
Ameritas Investment Partners
Nebraska
$80K
Acadian Asset Management
132
Acadian Asset Management
Massachusetts
$55K -$1.98M -62,247 -97%
NIT
133
NumerixS Investment Technologies
British Columbia, Canada
$48K -$78.9K -2,484 -59%
QT
134
Quantamental Technologies
New York
$37K +$41.3K +1,299 New
VCM
135
Versant Capital Management
Arizona
$28K -$88.2K -2,775 -74%
MAM
136
Meeder Asset Management
Ohio
$25K -$936K -29,477 -97%
KCM
137
Karp Capital Management
California
$24K +$26.5K +835 New
BNP Paribas Financial Markets
138
BNP Paribas Financial Markets
France
$21.1K -$35.7K -1,123 -60%
AG
139
Advisor Group
Arizona
$15K -$1.68K -53 -9%
IA
140
IFP Advisors
Florida
$14K -$15.9K -500 -50%
Fifth Third Bancorp
141
Fifth Third Bancorp
Ohio
$13K +$14.4K +452 New
LFG
142
Larson Financial Group
Missouri
$11K +$12.7K +400 New
Nisa Investment Advisors
143
Nisa Investment Advisors
Missouri
$7K
HR
144
Howe & Rusling
New York
$7K +$2.35K +74 +40%
PA
145
Parallel Advisors
California
$3K
BFC
146
Bedel Financial Consulting
Indiana
$1K
PNC Financial Services Group
147
PNC Financial Services Group
Pennsylvania
$1K
Northwestern Mutual Wealth Management
148
Northwestern Mutual Wealth Management
Wisconsin
$1K +$953 +30 New
Fuller & Thaler Asset Management
149
Fuller & Thaler Asset Management
California
-$8.77M -223,966 Closed
First Manhattan
150
First Manhattan
New York
-$5.33M -136,320 Closed

CSII Hedge Fund Activity: Q4 2018 in Review

148 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q4 2018, worth a combined $839M — down 26% from $1.13B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of CSII and 18 opened new positions — a net loss of 10 holders — while 49 trimmed existing stakes and 59 added.

The largest buyer was PFM Health Sciences, adding an estimated $18.5M. The largest seller was Deutsche Bank, cutting an estimated $17.2M.

  • 148 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q4 2018, down from 159 in Q3 2018.
  • Funds reported $839M of Cardiovascular Systems, Inc. stock for Q4 2018, down 26% quarter-over-quarter.
  • 18 funds opened new Cardiovascular Systems, Inc. positions in Q4 2018 and 28 closed out, a net change of -10 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q4 2018 was PFM Health Sciences, an estimated $18.5M added.
  • The largest Cardiovascular Systems, Inc. seller in Q4 2018 was Deutsche Bank, an estimated $17.2M sold.

Based on aggregated 13F filings for Q4 2018.